학술논문
181P Efficacy of eribulin mesylate in HER2-low metastatic breast cancer (MBC): Results from a pooled analysis of two phase III studies
Document Type
Abstract
Author
Source
In Annals of Oncology May 2022 33 Supplement 3:S210-S211
Subject
Language
ISSN
0923-7534